NHI.no
Annonse
Informasjon

Hemolytisk-uremisk syndrom (HUS)

Hemolytisk-uremisk syndrom (HUS) er en sykdom som oftest starter med en tarminfeksjon, og som etter noen dager fører til betennelse i nyrene. Dette er en alvorlig blod- og nyresykdom som først og fremst rammer småbarn og spedbarn.

Hemolytisk-uremisk syndrom medfører feber, redusert antall blodplater, skade på små blodkar, og anemi (nedsatt blodprosent).

Sist oppdatert:

12. okt. 2023

Dette dokumentet er basert på det profesjonelle dokumentet Hemolytisk-uremisk syndrom . Referanselisten for dette dokumentet vises nedenfor

  1. Michael M, Bagga A, Sartain SE, Smith RJH. Haemolytic uraemic syndrome. Seminar. Lancet 2022; 400: 1722-1740. pmid:36272423 PubMed
  2. Freedman SB, van de Kar NCAJ, Tarr PI. Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome. Review article. N Engl J Med 2023; 389: 1402-1414. doi:10.1056/NEJMra2108739 DOI
  3. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-87. New England Journal of Medicine
  4. Klein EJ, Stapp JR, Clausen CR, et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point of care study. J Pediatr 2002; 141: 172-77. PubMed
  5. Andreoli SP. The pathophysiology of the hemolytic uremic syndrome. Curr Opin Nephrol Hypertens 1999; 8: 459-64. PubMed
  6. Index of suspicion. Pediatr Rev 2002; 23: 433-8. PubMed
  7. Folkehelseinstituttet. Smittevernveilederen. E. coli-enteritt (inkludert EHEC-infeksjon og HUS) - veileder for helsepersonell. Smittevernveilederen, sist oppdatert 25.04.2022. Siden lest 11.11.2022 fhi.no
  8. Williams DM, Sreedhar SS, Mickell JJ, Chan JC. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med 2002; 156: 893-900. PubMed
  9. Andreoli SP. Acute renal failure. Curr Opin Pediatr 2002; 14: 183-8. PubMed
  10. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342: 1930-6. PubMed
  11. Chandler WL, Jelacic B, Boster DR, et al. Prothrombotic coagulation abnormalities associated with Escherichia coli O157:H7 infections. N Engl J Med 2002; 346: 23-32. PubMed
  12. Piercefield EW, Bradley KK, Coffman RL, Mallonee SM. Hemolytic uremic syndrome after an Eschericia coli O111 outbreak. Arch Intern Med 2010; 170: 1656-63. PubMed
  13. Razzaq S. Hemolytic uremic syndrome: An emerging health risk. Am Fam Physician 2006; 74: 991-6. PubMed
  14. Folkehelseinstituttet. Alvorlig E.coli-utbrudd er ikke over. Nyhetssak 10.10.2023. www.fhi.no
  15. Baylis CL, MacPhee S, Robinson AJ, Griffiths R, Lilley K, Betts RP. Survival of Escherichia coli O157:H7, O111:H- and O26:H11 in artificially contaminated chocolate and confectionery products. Int J Food Microbiol 2004; 96: 35-48. PubMed
  16. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1998; 19: 1102-08.
  17. Thorpe CM. Shiga toxin-producing Escherichia coli infection. Clin Infect Dis 2004; 38: 1298-303. PubMed
  18. Kakoullis L, Papachristodoulou E, Chra P, Panos G, et al. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview. J Infect. 2019; 79: 75-94. PMID: 31150744 PubMed
  19. Bayat A, Rittig S. Hæmolytisk uræmisk syndrom hos børn. Ugeskr Læger 2012; 174: 1302. Ugeskrift for Læger
  20. Khalid M, Andreoli S. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol. 2019; 34: 2495-2507. PMID: 30382336 PubMed
  21. Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003595. DOI: 10.1002/14651858.CD003595.pub2. DOI
  22. Tarr PI, Freedman SB. Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol. 2022; 38: 30-38. PMID: 34871193 PubMed
  23. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-86. PubMed
  24. Licht C, Greenbaum LA, Muus P, et al. Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int. 2015; 87: 1061-1073. PMID: 25651368 PubMed
  25. Rondeau E, Scully M, Ariceta G, et al. The long-acting C5 inhibitor, ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment. Kidney Int. 2020; 97: 1287-1296. PMID: 32299680 PubMed
Annonse
Annonse